Pulmonary fibrosis following therapy with Melphalan for multiple myeloma
Open Access
- 1 August 1972
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 25 (8) , 668-673
- https://doi.org/10.1136/jcp.25.8.668
Abstract
A patient suffering from multiple myeloma developed pulmonary fibrosis, of a type known to be associated wtih busulphan, whilst being treated with Melphalan. The possible role of Melphalan as the causative agent is discussed. Reference is made to other possible aetiological agents and the reasons for their exclusion are discussed.Keywords
This publication has 11 references indexed in Scilit:
- Oxygen alveolopathy in adultsClinical Radiology, 1972
- Bleomycin-induced interstitial pneumonia in dogsThorax, 1971
- Busulphan lungThorax, 1969
- Multiple Myeloma Presenting as Pulmonary Infiltration: Report of a CaseDiseases of the Chest, 1965
- Melphalan Therapy in MyelomatosisBMJ, 1964
- DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY.1963
- DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPYThe Lancet, 1963
- Development of radiation pneumonitis. Time and dose factors.1962
- Interstitial pulmonary fibrosis following busulfan therapyThe American Journal of Medicine, 1961
- "HEXAMETHONIUM LUNG". Report of a Case Associated with PregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1956